Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
| Author | |
|---|---|
| Abstract |
:
BM32 is a grass pollen allergy vaccine based on recombinant fusion proteins consisting of nonallergenic peptides from the IgE-binding sites of the 4 major grass pollen allergens and the hepatitis B preS protein. |
| Year of Publication |
:
2018
|
| Journal |
:
The Journal of allergy and clinical immunology
|
| Date Published |
:
2018
|
| ISSN Number |
:
0091-6749
|
| URL |
:
http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(17)31884-5
|
| DOI |
:
10.1016/j.jaci.2017.09.052
|
| Short Title |
:
J Allergy Clin Immunol
|
| Download citation |
